Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:26 AM ・ 2 min read ・ Source: PR Times
ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
Company Code: 4164 Company Name: ChienYeh Biotech Investment Holding Co., Ltd. Industry: Biotechnology and Medical Period: 2026 Q1 Basic Earnings Per Share: 0.13 NT Dollars Operating Revenue: 1.16 billion NT Dollars Net Profit After Tax: 0.36 billion NT Dollars
Keywords: Financial Report, Biotechnology and Medical, EPS
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.